Immunoswitch Nanomodulators’ Promise in Multiple Sclerosis Therapy: Targeting Regulatory T Cells and Inhibiting Effector T Cells’ Proliferation

https://pubmed.ncbi.nlm.nih.gov/38113242

Immunoswitch nanomodulators show promise in multiple sclerosis therapy by specifically targeting and promoting regulatory T cell proliferation while inhibiting effector T cell proliferation.